MedPath

LINE Re-education Before Colonoscopy to Confirm Optimal Bowel Cleansing

Not Applicable
Conditions
Bowel Cleansing
Interventions
Behavioral: LINE re-education
Registration Number
NCT04054388
Lead Sponsor
Taipei Medical University Hospital
Brief Summary

This is a prospective, colonoscopist-blinded, randomized, controlled study with consecutive outpatients undergoing colonoscopy in Taipei Medical University Hospital.The study would comply with the standards of the Declaration of Helsinki and current ethical guidelines. It have been approval by Taipei Medical University Institutional Review Board.

Detailed Description

Written informed consent will be obtained from all the patients. Patients will be randomized to either the LINE re-education or control group for colon preparation at the time of appointment for colonoscopy by using consecutively numbered envelopes that will contain the treatment assignments, which will be generated by a computer-allocated random digit number, in a 1:1 ratio. At least two LINE accounts for all patients or their relatives living together will be recorded in case of failure to contact. All patients will be instructed not to tell colonoscopists, nurses and investigators before, during and after the procedure about their preparation method and when they receive instructions.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Outpatients aged 18-80 years undergoing colonoscopy who will provide written informed consent will be eligible for participation in the study.
Exclusion Criteria
  • history of colorectal surgery;
  • severe colonic stricture or obstructing tumor;
  • uncooperative mental status;
  • significant ileus;
  • known or suspected bowel obstruction or perforation;
  • severe chronic renal failure (creatinine clearance <30 ml/min);
  • severe congestive heart failure (New York Heart Association class III or IV);
  • uncontrolled hypertension (systolic blood pressure >180 mm Hg, diastolic blood pressure>100 mm Hg);
  • liver cirrhosis;
  • toxic colitis or megacolon;
  • active gastrointestinal bleeding;
  • dehydration or disturbance of electrolytes;
  • pregnancy or lactation; and
  • hemodynamically unstable.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
300 Randomized to re-education groupLINE re-educationLINE re-education of colon preparation
Primary Outcome Measures
NameTimeMethod
Adequate bowel preparationDay 1

total Ottawa score \<6 or Boston bowel preparation scale ≥ 6

Secondary Outcome Measures
NameTimeMethod
cecal intubation rateDay 1

cecal intubation rate

colon polyp detection rateDay 1

colon polyp detection rate during colonoscopy

Trial Locations

Locations (1)

Taipei Medical University hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath